Search for: "Lowe v. Fisher" Results 161 - 172 of 172
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Oct 2008, 11:54 pm
The low infectious dose (very few bacteria) of pathogens such as E. coli O157:H7, other STECs, and Shigella increase the threat. [read post]
12 Jan 2012, 2:58 pm by Benjamin Wittes
 The Supreme Court has developed this concept further since Youngstown; the most frequently cited case is Dames & Moore v. [read post]
12 Nov 2007, 7:50 am
Cystic Fibrosis Chapter 6917 Arlington Road, Suite 308 Bethesda, MD 20814 Phone: (301) 657-8444; (877) 657-8444 (Toll Free) Fax: (301) 652-9571 E-mail: metro-dc@cff.org Web: http://www.cff.orgmetrodc.htm Developmental Disabilities State Developmental Disabilities Planning Council MD Developmental Disabilities Council 300 West Lexington Street, Box 10 Baltimore, MD 21201-2323 Phone: (410) 333-3688 (V/TTY); (800) 305-6441 (Toll Free in MD only) E-mail: info@md-council.org Web:… [read post]
15 Dec 2016, 7:35 am by Joy Waltemath
Wade, are in far less peril than more recent decisions, such as the affirmative action case of Fisher v. [read post]
25 Nov 2007, 7:20 am
Johns, MI 48879-2423 Phone: (989) 224-0333 (V/TTY); (800) 274-7426 (Toll Free) E-mail: matr@edzone.net Web: http://www.cenmi.org/matr Michigan Telework Loan Fund C/O U.C.P. [read post]
13 Apr 2024, 3:33 pm by admin
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]
16 Oct 2009, 3:18 pm
Submit written comments on the guidance to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. [read post]